Review of HIV and HCV infection among drug users in China

Current Opinion in Psychiatry

Volumn 23, Issue 3, 2010, Pages 187-194

  Bao, Yan Ping ^a   Liu, Zhi Min ^a   Lu, Lin ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

China; Drug users; HCV; HIV; Molecular epidemiology

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; KETAMINE; METHADONE; METHAMPHETAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHINA; DRUG DEPENDENCE; GEOGRAPHIC DISTRIBUTION; HARM REDUCTION; HEPATITIS C; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MEDICAL LITERATURE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MORBIDITY; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PROSTITUTION; PUBLIC HEALTH; REVIEW; TREND STUDY; VIRUS STRAIN; VIRUS TRANSMISSION;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMORBIDITY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DESIGNER DRUGS; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MOLECULAR EPIDEMIOLOGY; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 77952241929     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328338658b     Document Type: Review

References (74)

1. Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 2009;20:399-405. This study showed the pooled HIV and HCV infection prevalence among drug users, based on large sample size and large geography coverage in China.
2. Xia X, Luo J, Bai J, et al. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 2008;122:990-1003. This study showed the pooled HCV prevalence and possible high-risk factors of HCV infection among injection drug users in China.
3. Yu XF, Chen J, Shao Y, et al. Two subtypes of HIV-1 among injection-drug users in southern China. Lancet 1998;351:1250.
4. Cheng H, Zhang J, Capizzi J, et al. HIV-1 subtype E in Yunnan, China. Lancet 1994;344:953-954.
5. Piyasirisilp S, McCutchan FE, Carr JK, et al. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000;74:11286-11295.
6. Tee KK, Pybus OG, Li XJ, et al. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08-BC and 07-BC in Asia. J Virol 2008;82:9206-9215. This study is the first genealogy-based population genetic study of the divergence times of different CRF HIV subtypes across China, by reconstructing the evolutionary histories of these strains using recently developed Bayesian analysis methods.
7. Xia X, Lu L, Tee KK, et al. The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol 2008;80:1142-1152.
8. Tan Y, Wei QH, Chen LJ, et al. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One 2008;3:e3608. This study revealed that genotype 6a was predominant in injection drug users in southern China and there were shorter genetic distances among the 6a sequences than among the other HCV subtypes 1a, 3a, and 3b.
9. Garten RJ, Zhang J, Lai S, et al. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 2005;41 (Suppl 1) :S18-S24.
10. Peng JS, Wang X, Liu MQ, et al. Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China. Virus Res 2008;135:1 91-1 96.
11. Zhou DX, Tang JW, Chu IM, et al. Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong. J Med Virol 2006;78:574-581.
12. Liu JY, Lin HH, Liu YC, et al. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin Infect Dis 2008;46:1761-1768.
13. Bao YP, Liu ZM. Current situation and trends of drug abuse and HIV/AIDS in China. HIV Ther 2009;3:237-240.
14. National Narcotic Control Commission. The registered drug users in China reach 1.33 million at 2009. http://www.mps.gov. cn/n16/n1252/n1897/n2872/ 2327636.html. This is the updated report from the Chinese government (National Narcotic Control Commission) about registered drug users in China.
15. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China, 2003. Edited by State Council AIDS working Committee Office.
16. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China, 2007. State Council AIDS working Committee Office.
17. Liu ZM, Cao JQ, Lu XX, et al. Epidemiology study of central stimulants and other related psychoactive substance abuse. Chin J Drug Depend 2002;11: 286-293.
18. SutcliffeCG, Aramrattana A, Sherman SG, et al. Incidence of HIV and sexually transmitted infections and risk factors for acquisition among young methamphetamine users in northern Thailand. Sex Transm Dis 2009;36:284-289. This study indicated the high risk of HIV infection and other sexually transmitted diseases among methamphetamine users and emphasizes the need for new prevention strategies targeted toward them.
19. Cartier JJ, Greenwell L, PrendergastML. The persistence of HIV risk behaviors among methamphetamine-using offenders. J Psychoactive Drugs 2008;40: 437-446.
20. Wang YF, Zhang YZ, Lian Z, et al. Epidemiological characteristics of three new drugs abuse in Beijing. Chin J Drug Depend 2008;17:445-454. This study is the systematic introduction of the characteristics of several 'new drugs' abused in China.
21. Liu ZM, Zhou WH, Lian Z, et al. Epidemiological survey on poly-drug abuse among drug addicts. Chin J Clin Pharmacol 2000;16:272-276.
22. Zheng X, Tian C, Choi KH, et al. Injecting drug use and HIV infection in southwest China. AIDS 1994;8:1141-1147.
23. The Ministry of Health introduced the AIDS epidemic status of 2009 in China. http://www.moh.gov. cn/publicfiles/business/htmlfiles/mohbgt/s3582/ 200911/44754.htm This is the updated report on HIV/AIDS in China. Infection through sexual transmission and MSM increased quickly and should receive attention.
24. Beyrer C, Razak MH, Lisam K, et al. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000;14:75-83.
25. Yang R, Xia X, Kusagawa S, et al. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS 2002;16:1401-1407.
26. Ruan Y, Qin G, Liu S, et al. HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China. J Acquir Immune Defic Syndr 2005;39:459-463.
27. Zhang Y, Lu L, Ba L, et al. Dominance of HIV-1 subtype CRF01-AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med 2006;3:e443.
28. Shao YM, Guan UJ, Zhao QB, et al. Genetic variations and molecular epidemiology of the Ruili HIV-1 strains of Yunnan in 1 995. Chin J Virol 1996;12:9-1 7.
29. Shao YM, Zhao CB, Wang B, et al. Sequence analysis of HIV env genes among HIV infected drug infection users in Dehong epidemic area of Yunan Province, China. Chin J Virol 1994;10:291-299.
30. Teng ZP, Zhu TF, Duan YJ, et al. The HIV molecular epidemiology analysis among HIV infected cases in Ruili city of Yunnan Province, China. Chin J STD/AIDS Prev Cont 1995;1:1-5.
31. Chen J, Guan YJ, Shao YM, et al. Subtype and sequence analysis of the C2-C3 region of gp120 gene among HIV-1 infected IDUs in Longchuan epidemic area of Yunnan province, China. Chin J Microbiol Immunol 1997;17: 1-6.
32. Guan YJ, Chen J, Shao YM, et al. Subtype and sequence analysis of the C2-V3 region of gp120 genes among human immunodeficiency virus infected IDUs in Ruili epidemic area of Yunnan province of China. Chin J Exp Clin Virol 1997;11:8-12.
33. Li XJ, Xia XS, Takebe Y, et al. Molecular epidemiology of HIV-1 transmission among Injecting drug Users and heterosexuals in Kunming. Chin J Dermatovenereol 2009;23:294-295.
34. Qin GM, Shao YM, Liu G, et al. Subtype and sequence analysis of the C2-V3 region of gp120 genes among HIV-1 strains in Sichuan province. Chin J Epidemiol 1998;19:39-42.
35. Shao YM, Zhao F, Yang WZ, et al. The identification of recombinant HIV-1 strains in IDUs in southwest and northwest China. Chin J Exp Clin Virol 1999;13: 109-112.
36. Ling H, Xin H, Han M, et al. Subtype and sequence analysis on HIV-1 strains circulating in Chongqing. Chin J AIDS STD 2005;11:345-347.
37. Li ZD, Xu ZK, Zhang L, et al. Study of the molecular epidemiology of HIV-1 in Shannxi province. Chin J Dermatovenereol 2003;17:12-15.
38. Wang BT, Xin H, Yu AL, et al. Subtype and sequence analysis on HIV-1 strains circulating in Gansu province. Chin J AIDS STD 2005;11:348-349.
39. Bai XH, Guan YJ, Zhang YZ, et al. Subtype and sequence analysis of the C2-V3 region of genes of membrane protein among HIV-1 strains in Wulumuqi epidemic area of Xinjiang. Chin J Virol 1997;13:339-343.
40. Liu S, Xing H, He X, et al. Dynamic analysis of genetic diversity of gag and env regions of HIV-1 CRF07-BC recombinant in intravenous drug users in Xinjiang Uvghur Autonomous Region, China. Arch Virol 2008;153:1 233-1 240.
41. Ma L, Guo Y, Yuan L, et al. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07-BC strains circulating in the Xinjiang Province of China. Retrovirology 2009;6:45.
42. Fu JH, Li CS, Zhang J, et al. Study on the molecular epidemiology of people infected with human immunodeficiency virus 1 in Shandong province. Chin J Epidemiol 2005;26:124-127.
43. Liu LH, Yang LH, ZhaoXR, et al. Subtype distribution of HIV-1 among different people infected. Chin J Pub Health 2009;25:1023-1024.
44. Jia CM, Yang HT, Xu XQ, et al. Seroepidemiology and molecular epidemiology study on HIV infection in Jiangsu province. Chin J Pub Health 2002;18: 1090-1091.
45. Yang HT, Xin H, Jia CM, et al. A molecular epidemiology study on the human immunodeficiency virus infection in Jiangsu province. Chin J Epidemiol 2003;24: 976-979.
46. Yang HT, Xu XQ, Qiu T, et al. Molecular epidemiology of the human immunodeficiency virus-1 isolated from patients confirmed lately in Jiangsu province. Acta Univ Med Nanjing 2009;29:976-980.
47. Lin YT, Lan YC, Chen YJ, et al. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07-BC strains from injection drug users in Taiwan. J Infect Dis 2007;195:1283-1293.
48. Wu NP, Liu KZ, Chen Z, et al. Detection of HIV nucleic acid and subtype analysis in 15 intravenous drug abusers. Chin J Infect Dis 2003;21:14-16.
49. Pan XH, Yao YP, XiaSC, et al. Molecular epidemiology study of HIV infection cases in 2003-2005 in Zhejiang province. Chin J AIDS STD 2007;13:308-311.
50. Zhao F, Cui ZL, Wang C, et al. Molecular epidemiology investigation of HIV-1 among drug users of 2006-2008 in Henan province. J Hygiene Res 2009;38: 574-575.
51. Chen JSL, Liang SL, Liu W, et al. Subtypes and sequence analysis of the C2-V3 region of gp120 genes among HIV-1 strains in Guangxi autonomous region of the Zhuangs. Chin J Virol 1998;14:240-245.
52. Chen J, Liu W, Young NL, et al. Molecular epidemiology analysis of HIV-1 initial prevalence in Guangxi, China. Chin J Epidemiol 1999;20:74-77.
53. Liang SL, Liang FX, Chen J, et al. Study on molecular epidemiology of HIV/AIDS among drug users in Guangxi. J Appl Prev Med 2007;13:263-267.
54. Pan PL, Zeng CH, Fan XJ, et al. Identification and characterization of human immunodeficiency virus type 1 subtype F env gene in China. Chin J Virol 1999;15: 97-101.
55. Yan J, Wang Y, Li J, et al. Subtype and sequence analysis of the env gene in HIV-1 infected drug users in Guangdong. Chin J AIDS STD 2005;11:9-12.
56. Yan J, Wang Y, Li J, et al. Molecular epidemiology investigation on HIV-1 epidemic strain. Chin J Public Health 2005;21:90-91.
57. Feng TJ, Shao YM, Li LC, et al. Subtype and sequence analysis of the C2-V3 region of gp120 genes among HIV-1 strains in Shenzhen. Chin J Clin Infect Dis 1998;16:202-205.
58. Feng TJ, Li LC, He JF, et al. Analysis on HIV/AIDS epidemic in Shenzhen. Chin J AIDS STD 2000;6:100-103.
59. Zhang Y, Zhao GL, Huang X, et al. Epidemiological survey of human immunodeficiency virus type 1 in drug users in Shenzhen. Chin Trop Med 2009;9:994-996. This study explains the high incidence of AE and the possible reason.
60. Liu JF, Yan YS, Lin X, et al. Genetic subtype and epidemiology feature of HIV-1 circulating strains in Fujian province. Chin J Zool 2006;22:601-608.
61. Fu P, Deng W, Bao LL, et al. HIV-1 gene subtypes in HIV positives and AIDS patients in Hainan province. Chin J Public Health 2009;25:1142-1143. This study showed that the HIV-1 AE subtype was predominant among drug users in Southern China, which indicates that the sexual transmission among drug users complicates the situation of HIV infection.
62. Hu GL, Yi ZQ, Zhou XF, et al. Analysis of characterization of HIV-1 gene sequences in Jiangxi province. Chin J AIDS STD 2005;11:1-5.
63. Chen X, Xin H, He JM, et al. A molecular epidemiology study on HIV-1 infection in Hunan prvince. Pract Prev Med 2005;12:483-485.
64. Yu XF, Chen J, Shao Y, et al. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr 1999;22: 180-188.
65. Graf M, Shao Y, Zhao Q, et al. Cloning and characterization of a virtually fulllength HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses 1998;14: 285-288.
66. Luo CC, Tian C, Hu DJ, et al. HIV-1 subtype C in China. Lancet 1995;345: 1051-1052.
67. Su L, Graf M, Zhang Y, et al. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol 2000;74:11367-11376.
68. Lu L, Jia M, Ma Y, et al. The changing face of HIV in China. Nature 2008;455: 609-611. This study emphasized that HIV-1 prevention strategies in China must focus more on stopping sexual transmission of HIV-1 within high-risk groups and halting the spread to the general public.
69. Lau JT, Tsui HY, Zhang Y, et al. Comparing HIV-related syringe-sharing behaviors among female IDU engaging versus not engaging in commercial sex. Drug Alcohol Depend 2008;97:54-63. This study showed that female IDUs involved in sex work are at high risk of HIV transmission. The bridging effect poses a threat to the HIV epidemic in China and effective preventive services are warranted.
70. Gu J, Chen H, Chen X, et al. Severity of drug dependence, economic pressure and HIV-related risk behaviors among noninstitutionalized female injecting drug users who are also sex workers in China. Drug Alcohol Depend 2008;97: 257-267.
71. Gu J, Wang R, Chen H, et al. Prevalence of needle sharing, commercial sex behaviors and associated factors in Chinese male and female injecting drug user populations. AIDS Care 2009;21:31-41.
72. Lu L, Nakano T, He Y, et al. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 2005;75:538-549.
73. Verucchi G, Calza L, Manfredi R, et al. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004;32:33-46.
74. Wu Z, Sullivan SG, Wang Y, et al. Evolution of China's response to HIV/AIDS. Lancet 2007;369:679-690.